OraSure gets wider use for hep C test, shares up
November 29, 2011 at 16:13 PM EST
Nov 29 (Reuters) - OraSure Technologies received approval to sell its test for the hepatitis C virus to a wider range of clinics and doctors' offices in the United States, sending shares of the company up nearly 9 percent.